Have a new drug that promis­es to fight Covid-19? The FDA promis­es fast ac­tion but some de­vel­op­ers aren't hap­py

Af­ter pro­vid­ing an emer­gency ap­proval to use malar­ia drugs against coro­n­avirus with lit­tle ac­tu­al ev­i­dence of their ef­fi­ca­cy or safe­ty in that set­ting, the FDA has al­ready proven that it has set aside the gold stan­dard when it comes to the pan­dem­ic. And now reg­u­la­tors have spelled out a new ap­proach to speed­ing de­vel­op­ment that promis­es im­me­di­ate re­spons­es in no un­cer­tain terms — promis­ing a pro­gram of­fer­ing the ul­ti­mate high-speed path­way to Covid-19 drug ap­provals.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER